Ipa (Immunoprecise Antibodies)

Ipa (Immunoprecise Antibodies) company information, Employees & Contact Information

IPA is a progressive, scientific Contract Research Organization (CRO) recently ranked by one of the pharmaceutical industry’s most trusted, independent market research sources with the highest competitive score, for its antibody service portfolio.1 The company represents a HUB of biotherapeutic intelligence that includes a hybrid of experts and technologies, in the science and business of bioplatform-based discovery. We provide highly specialized full-continuum therapeutic antibody discovery, development, and out-licensing services [Talem] —with advanced omics and complex intelligence technology [LENSai] that provide greater efficiency and accuracy than ever before. Our mission is to provide our pharmaceutical customers with a HUB of the most advanced intelligence and technology to treat disease, bar none. Our goal — is to improve the specificity of biotherapeutics by unlocking the language of the genome. #Antibodies #AI 1. ROOTS 2022: Antibody Discovery Services and Platforms Market (Industry Trends and Global Forecast, 4th Edition), 2021-2035; p.118

Company Details

Employees
91
Founded
-
Address
823 Congress Ave, Austin,texas 78701,united States
Phone
1-250-483-0308
Email
co****@****ise.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Austin, Texas
Looking for a particular Ipa (Immunoprecise Antibodies) employee's phone or email?

Ipa (Immunoprecise Antibodies) Questions

News

ImmunoPrecise evolves into MindWalk to reflect AI-focused future - Fierce Pharma

ImmunoPrecise evolves into MindWalk to reflect AI-focused future Fierce Pharma

ImmunoPrecise Antibodies (IPA) Reports Full Fiscal Year 2025 Results, Record Fourth Quarter Revenue, and Record Fourth Quarter Adjusted EBITDA - Business Wire

ImmunoPrecise Antibodies (IPA) Reports Full Fiscal Year 2025 Results, Record Fourth Quarter Revenue, and Record Fourth Quarter Adjusted EBITDA Business Wire

ImmunoPrecise Antibodies’ LENSai Platform Achieves Breakthrough in Epitope Mapping Accuracy - Yahoo Finance

ImmunoPrecise Antibodies’ LENSai Platform Achieves Breakthrough in Epitope Mapping Accuracy Yahoo Finance

ImmunoPrecise uses AI to identify universal target for dengue vaccine - FirstWord Pharma

ImmunoPrecise uses AI to identify universal target for dengue vaccine FirstWord Pharma

Leading Biotech ImmunoPrecise Antibodies Joins Major H.C. Wainwright Investment Conference in New York - Stock Titan

Leading Biotech ImmunoPrecise Antibodies Joins Major H.C. Wainwright Investment Conference in New York Stock Titan

ImmunoPrecise teases $10M ADC, bispecific collab with major biotech - Fierce Biotech

ImmunoPrecise teases $10M ADC, bispecific collab with major biotech Fierce Biotech

Reena Patel Interviews Jennifer Bath, CEO and President of ImmunoPrecise Antibodies - citybiz

Reena Patel Interviews Jennifer Bath, CEO and President of ImmunoPrecise Antibodies citybiz

™ Quickly Flags Anti-Drug-Antibody Risk—Long Before the Clinic - Business Wire

™ Quickly Flags Anti-Drug-Antibody Risk—Long Before the Clinic Business Wire

ImmunoPrecise Regains Compliance with Nasdaq Minimum Bid Price Requirement - Yahoo Finance

ImmunoPrecise Regains Compliance with Nasdaq Minimum Bid Price Requirement Yahoo Finance

We're Keeping An Eye On ImmunoPrecise Antibodies' (NASDAQ:IPA) Cash Burn Rate - Yahoo Finance

We're Keeping An Eye On ImmunoPrecise Antibodies' (NASDAQ:IPA) Cash Burn Rate Yahoo Finance

ImmunoPrecise Rebrands as MindWalk, Announces NASDAQ Ticker Change to “HYFT” - Business Wire

ImmunoPrecise Rebrands as MindWalk, Announces NASDAQ Ticker Change to “HYFT” Business Wire

ImmunoPrecise Antibodies Ltd. Divests Netherlands Facilities to AVS Bio to Accelerate Bio-Native AI Innovation - Business Wire

ImmunoPrecise Antibodies Ltd. Divests Netherlands Facilities to AVS Bio to Accelerate Bio-Native AI Innovation Business Wire

ImmunoPrecise Antibodies Ltd. (IPA) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance

ImmunoPrecise Antibodies Ltd. (IPA) Reports Q4 Loss, Lags Revenue Estimates Yahoo Finance

ImmunoPrecise Validates LENSai Epitope Mapping Platform Across Broad Range of Unseen Therapeutic Targets Beyond Training Data - Yahoo Finance

ImmunoPrecise Validates LENSai Epitope Mapping Platform Across Broad Range of Unseen Therapeutic Targets Beyond Training Data Yahoo Finance

ImmunoPrecise Antibodies Appoints Industry Veteran Jon Lieber to Board of Directors - Business Wire

ImmunoPrecise Antibodies Appoints Industry Veteran Jon Lieber to Board of Directors Business Wire

ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025 - Yahoo Finance

ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025 Yahoo Finance

ImmunoPrecise Appoints Healthcare Data Visionary Jeff Fried to Advisory Board - Yahoo Finance

ImmunoPrecise Appoints Healthcare Data Visionary Jeff Fried to Advisory Board Yahoo Finance

ImmunoPrecise Antibodies Full Year 2025 Earnings: Misses Expectations - Yahoo Finance

ImmunoPrecise Antibodies Full Year 2025 Earnings: Misses Expectations Yahoo Finance

ImmunoPrecise Antibodies Highlights Alignment of Proprietary AI-Driven Platform LENSai™ with FDA's Shift to Non-Animal Testing Methods - Yahoo Finance

ImmunoPrecise Antibodies Highlights Alignment of Proprietary AI-Driven Platform LENSai™ with FDA's Shift to Non-Animal Testing Methods Yahoo Finance

ImmunoPrecise Advances AI Discovered and Developed Universal Dengue Vaccine Initiative: Moves into Preclinical Antibody Generation - Yahoo Finance

ImmunoPrecise Advances AI Discovered and Developed Universal Dengue Vaccine Initiative: Moves into Preclinical Antibody Generation Yahoo Finance

ImmunoPrecise Antibodies to Present at Global Investment Conference - TipRanks

ImmunoPrecise Antibodies to Present at Global Investment Conference TipRanks

IPA (ImmunoPrecise Antibodies) Pioneers AI-Designed GLP-1 Therapies: A Potential New Chapter in Diabetes Treatment - Business Wire

IPA (ImmunoPrecise Antibodies) Pioneers AI-Designed GLP-1 Therapies: A Potential New Chapter in Diabetes Treatment Business Wire

ImmunoPrecise Subsidiary Signs Material Transfer Agreement with Biotheus - Business Wire

ImmunoPrecise Subsidiary Signs Material Transfer Agreement with Biotheus Business Wire

ImmunoPrecise Antibodies Receives Nasdaq Notification Regarding Minimum Bid Requirements - Business Wire

ImmunoPrecise Antibodies Receives Nasdaq Notification Regarding Minimum Bid Requirements Business Wire

H.C. Wainwright sets $50 target for ImmunoPrecise stock - Investing.com

H.C. Wainwright sets $50 target for ImmunoPrecise stock Investing.com

Will ImmunoPrecise Antibodies (NASDAQ:IPA) Spend Its Cash Wisely? - simplywall.st

Will ImmunoPrecise Antibodies (NASDAQ:IPA) Spend Its Cash Wisely? simplywall.st

Why Is ImmunoPrecise Antibodies (IPA) Stock Down 39% Today? - InvestorPlace

Why Is ImmunoPrecise Antibodies (IPA) Stock Down 39% Today? InvestorPlace

IPA to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2023 on September 14, 2022 - FinancialContent

IPA to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2023 on September 14, 2022 FinancialContent

IPA Announces Agreement to Acquire BioStrand BV – Revolutionizing Biotherapeutics with Methodology to Encode Omics and Power Drug Development with Advanced Artificial Intelligence - Business Wire

IPA Announces Agreement to Acquire BioStrand BV – Revolutionizing Biotherapeutics with Methodology to Encode Omics and Power Drug Development with Advanced Artificial Intelligence Business Wire

ImmunoPrecise Antibodies (IPA) Stock Price, News & Analysis - MarketBeat

ImmunoPrecise Antibodies (IPA) Stock Price, News & Analysis MarketBeat

Top Ipa (Immunoprecise Antibodies) Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant